The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Circulating tumor cell (CTC) rise and outcome in patients with metastatic castration-resistant prostate cancer (mCRPC) with low baseline CTC counts.
 
David Lorente
Travel, Accommodations, Expenses - Ipsen
 
David Olmos
No Relationships to Disclose
 
Joaquin Mateo
No Relationships to Disclose
 
Zafeiris Zafeiriou
No Relationships to Disclose
 
Pasquale Rescigno
No Relationships to Disclose
 
Diletta Bianchini
No Relationships to Disclose
 
Niven Mehra
No Relationships to Disclose
 
Arturo Molina
Employment - Janssen Research & Development
 
Thian Kheoh
Employment - Janssen Research & Development
 
Kurt Baeten
Employment - Janssen Diagnostics
 
Robert Thomas Mccormack
Employment - Janssen; Veridex
 
Leon W M M Terstappen
No Relationships to Disclose
 
Howard I. Scher
Consulting or Advisory Role - Astellas Pharma; BIND Therapeutics; Blue Earth Diagnostics; Bristol-Myers Squibb; Celgene; Elsevier; Ferring; Janssen; Med IQ; Medivation; OncologySTAT; Pfizer; Roche; Sanofi; Takeda-Millennium; WIRB-Copernicus Group
Speakers' Bureau - WebMD
Research Funding - BIND Biosciences (Inst); Exelixis (Inst); Innocrin Pharma (Inst); Janssen (Inst); Janssen Diagnostics (Inst); Medivation (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; BIND Therapeutics; Ferring; Medivation; Pfizer; Roche; Sanofi; Takeda; WIRB-Copernicus Group
 
Johann de Bono
No Relationships to Disclose
 
Johann S. De Bono
Honoraria - Astellas Pharma; AstraZeneca; Genentech/Roche; Pfizer; Sanofi
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Genentech/Roche; Sanofi
Research Funding - AstraZeneca (Inst); Genentech (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Abiraterone Rewards to Inventors (Inst); PARP inhibitors and DNA repair defects (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Genmab; GlaxoSmithKline; Orion; Qiagen; Sanofi; Taiho Pharmaceutical; Vertex